Venus Remedies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venus Remedies Limited submitted its yearly promoter disclosure under SEBI (SAST) Regulations. Promoter Pawan Chaudhary, on behalf of himself and the promoter group (including Manu Chaudhary, Peeyush Jain, Ashutosh Jain, Akshansh Chaudhary, and Sunev Pharma Solutions Pvt Ltd), declared that no encumbrance of shares was created or released during the period. The disclosure confirms that as of March 31, 2026, no equity shares held by the promoters or promoter group are pledged or encumbered. This is a standard nil-disclosure filing required annually under SEBI regulations.
The nil encumbrance declaration is a positive signal for investors as it indicates promoters have not leveraged their shareholding through pledging, reducing risk of potential sudden selling pressure.